Read about the latest news in Philippines, local news, breaking news, world news, odd news, opinion, and view news photos and videos
Sunday, July 2, 2023
🌎 The Week Ahead for 7/2/2023
Ratings changes for T2 Biosystems, Galectin Therapeutics, Oncternal Therapeutics, Heska, Heat Biologics, II-VI, La Jolla Pharmaceutical and more...Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial. Unsubscribe.
VIEW MY PORTFOLIO
July 2nd, 2023
Get Ready for the Impending Crisis: Are You Prepared? (ad)
It's time to face the harsh reality: the stability of the dollar is no longer guaranteed. The national debt is spiraling out of control, inflation is on the rise, and the government seems powerless to rein it in. These warning signs strongly suggest an impending collapse of the dollar, with catastrophic consequences looming over us. By clicking link you are subscribing to The Darwin Investor Network and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Thursday, July 6: Coca-Cola Europacific Partners PLC (CCEP),
Sell every Stock except ONE (ad)
Markets are down... But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month...
Our financial system is about to be transformed in a way that would've been unthinkable just a few years ago. To show you everything you need to know about the FedNow system - and to help you prepare - Dr. Prins has recorded a free presentation with all the details. It's controversial, but Nomi's interview is a must-watch for anyone with more than $2,500 in an American bank or retirement fund.
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET.
UPGRADE NOW
Manage Your Watchlist
View and add up to five holdings to your watchlist.
VIEW MY PORTFOLIO
Join Our Facebook Group
Join MarketBeat's free stock discussion and trading idea group on Facebook.
JOIN NOW
Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com or leave us a voicemail at (844) 978-6257.
No comments:
Post a Comment